PMID- 17064675 OWN - NLM STAT- MEDLINE DCOM- 20070709 LR - 20220225 IS - 0008-6363 (Print) IS - 0008-6363 (Linking) VI - 72 IP - 3 DP - 2006 Dec 1 TI - Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. PG - 447-55 AB - OBJECTIVE: We investigated the role of NADPH oxidase 4 (Nox4) on lipopolysaccharide (LPS)-induced proinflammatory responses by human aortic endothelial cells (HAECs). METHODS AND RESULTS: Yeast two-hybrid and glutathione-S-transferase pull-down assays indicated that the cytosolic Toll/IL-1R region of Toll-like receptor 4 (TLR4) (amino acids 739-769) is the responsible domain for interaction with the COOH terminal of Nox4 (amino acids 451-530). Consistently, overexpression of the COOH-terminal region of Nox4 inhibited nuclear factor-kappaB activation in response to LPS. Downregulation of Nox4 by transfection of siRNA specific to Nox4 in HAECs resulted in a failure to induce reactive oxygen species (ROS) generation and subsequent expression of intercellular adhesion molecule-1 (ICAM-1) and chemokines such as IL-8 and monocyte chemoattractant protein-1 (MCP-1) in response to LPS. Furthermore, transient transfection of endothelial cells with Nox4 siRNA led to a decrease in migration and adhesion of monocytes in response to LPS by 36% and 52%, respectively. CONCLUSIONS: Nox4 plays a central role in LPS-induced proinflammatory responses by endothelial cells in an ROS-dependent manner. FAU - Park, Hye Sun AU - Park HS AD - Division of Molecular Life Sciences, Center for Cell Signaling Research, Ewha Womans University, 11-1 Daehyun-Dong, Seodaemoon-Gu, Seoul 120-750, Republic of Korea. FAU - Chun, Jung Nyeo AU - Chun JN FAU - Jung, Hye Young AU - Jung HY FAU - Choi, Chulhee AU - Choi C FAU - Bae, Yun Soo AU - Bae YS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060923 PL - England TA - Cardiovasc Res JT - Cardiovascular research JID - 0077427 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-8) RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (RNA, Small Interfering) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - BBX060AN9V (Hydrogen Peroxide) RN - EC 1.6.3.- (NADPH Oxidase 4) RN - EC 1.6.3.- (NADPH Oxidases) RN - EC 1.6.3.- (NOX4 protein, human) SB - IM MH - Aorta MH - Bacterial Infections/enzymology/*immunology MH - Cell Adhesion/drug effects MH - Cell Movement/drug effects MH - Cell Nucleus/metabolism MH - Cells, Cultured MH - Chemokine CCL2/analysis MH - Endothelial Cells/enzymology/*immunology MH - Humans MH - Hydrogen Peroxide/analysis MH - Intercellular Adhesion Molecule-1/analysis MH - Interleukin-8/analysis MH - Lipopolysaccharides/pharmacology MH - Monocytes/drug effects MH - NADPH Oxidase 4 MH - NADPH Oxidases/genetics/*physiology MH - NF-kappa B/metabolism MH - Protein Binding MH - RNA Interference MH - RNA, Small Interfering/pharmacology MH - Reverse Transcriptase Polymerase Chain Reaction MH - Transfection/methods MH - Two-Hybrid System Techniques EDAT- 2006/10/27 09:00 MHDA- 2007/07/10 09:00 CRDT- 2006/10/27 09:00 PHST- 2006/05/03 00:00 [received] PHST- 2006/07/21 00:00 [revised] PHST- 2006/09/18 00:00 [accepted] PHST- 2006/10/27 09:00 [pubmed] PHST- 2007/07/10 09:00 [medline] PHST- 2006/10/27 09:00 [entrez] AID - S0008-6363(06)00411-1 [pii] AID - 10.1016/j.cardiores.2006.09.012 [doi] PST - ppublish SO - Cardiovasc Res. 2006 Dec 1;72(3):447-55. doi: 10.1016/j.cardiores.2006.09.012. Epub 2006 Sep 23.